U2OS-CRISPR-NUP96-mEGFP Cells
€800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The U-2 OS-CRISPR-NUP96-mEGFP is a genetically modified cell line derived from the human osteosarcoma U-2 OS parent line. This cell line incorporates a targeted insertion of the monomeric Enhanced Green Fluorescent Protein (mEGFP) tag at the NUP96 gene locus, achieved through the CRISPR-Cas9 gene-editing technology. NUP96, part of the nuclear pore complex, is essential for nuclear transport, and its fusion with mEGFP allows for real-time visualization of nuclear pore dynamics under fluorescent microscopy, providing valuable insights into nuclear transport mechanisms and nucleocytoplasmic trafficking. This specific clone, numbered 195, has been selected for its stable expression of the NUP96-mEGFP fusion protein and maintains the typical characteristics of the U-2 OS lineage, including a robust cytoskeletal structure which is critical in studies related to cancer cell migration and metastasis. The application of CRISPR technology ensures precise gene editing, minimizing off-target effects which could compromise the integrity of the experimental outcomes. This makes U-2 OS-CRISPR-NUP96-mEGFP clone no.195 particularly useful for high-resolution imaging techniques and detailed cellular architecture studies, aiding in advanced research in cellular biology, cancer research, and nuclear transport phenomena. |
|---|---|
| Organism | Human |
| Tissue | Bone |
| Disease | Osteosarcoma |
Characteristics
| Age | 15 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Epithelial-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | U-2 OS-CRISPR-NUP96-mEGFP clone no.195 (Cytion catalog number 300174) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_B7FJ |
| Depositor | The Ellenberg Lab (EMBL) |
| GMO Status | GMO-S1: This human osteosarcoma cell line (U2OS-CRISPR-NUP96-mEGFP, clone 195) contains a CRISPR-engineered NUP96-mEGFP fusion introduced via lentiviral delivery, enabling fluorescent tracking of nuclear pore complexes. The modification is stably integrated. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Protein expression | MEGFP (nuclear pore complex protein 96, mEGFP tagged) |
|---|
Handling
| Culture Medium | McCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS, 1% NEAA |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 2 to 3 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300174-130226 | Certificate of Analysis | 13. Mar. 2026 | 300174 |
| 300174-151124 | Certificate of Analysis | 23. May. 2025 | 300174 |
| 300174-322 | Certificate of Analysis | 23. May. 2025 | 300174 |